Acetylcholinesterase antagonist potentiated insulin action in fed but not fasted state

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 2, 2010, Pages 621-628

  Schafer, Joshua ^a   Legare, Dallas J ^a   Wayne Lautt, W ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ATROPINE; GLUTATHIONE; ISOPHANE INSULIN; NEOSTIGMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPETITIVE INHIBITION; CONTINUOUS INFUSION; CONTROLLED STUDY; DENERVATION; DOSE RESPONSE; DRUG MEGADOSE; DRUG POTENTIATION; INSULIN LIKE ACTIVITY; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; NONHUMAN; PARASYMPATHETIC FUNCTION; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; SENSITIZATION;

ACETYLCHOLINESTERASE; ANIMALS; ATROPINE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FASTING; GLUCOSE CLAMP TECHNIQUE; GLUTATHIONE; INSULIN; INSULIN RESISTANCE; LIVER; NEOSTIGMINE; POSTPRANDIAL PERIOD; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77951069143     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.164509     Document Type: Article

References (26)

1. Guarino MP, Afonso RA, Raimundo N, Raposo JF, and Macedo MP (2003) Hepatic glutathione and nitric oxide are critical for hepatic insulin-sensitization substance action. Am J Physiol Gastrointest Liver Physiol 284:G588-G594. (Pubitemid 36343208)
2. Guarino MP, Correia NC, Lautt WW, and Macedo MP (2004) Insulin sensitivity is mediated by the activation of the Ach/NO/cGMP pathway in rat liver. Am J Gastrointest Liver Physiol 287:G527-G532. (Pubitemid 39096617)
3. Khamaisi M, Kavel O, Rosenstock M, Porat M, Yuli M, Kaiser N, and Rudich A (2000) Effect of inhibition of glutathione synthesis on insulin action: in vivo and in vitro studies using buthionine sulfoxamine. Biochem J 349:579-586. (Pubitemid 30465793)
4. Lautt WW (1999) The HISS story overview: a novel hepatic neurohumoral regulation of peripheral insulin sensitivity in health and diabetes. Can J Physiol Pharmacol 77:553-562.
5. Lautt WW (2003) New paradigm for insulin resistance: the HISS story. Metab Syndr Relat Dis 1:261-270.
6. Lautt WW (2004) A new paradigm for diabetes and obesity: the hepatic insulinsensitizing substance (HISS) hypothesis. J Pharmacol Sci 95:9-17.
7. Lautt WW (2005) inventor; DiaMedica Inc., assignee. Use of cholinesterase antagonists to treat insulin resistance. U.S. Patent Publication No. US2005/0049293 A1. 2005 Mar 3.
8. Lautt WW (2007) Postprandial insulin resistance as an early predictor of cardiovascular risk. Therapeut Clin Risk Managem 3:761-770. (Pubitemid 350162076)
9. Lautt WW and Ming Z (2010) Use of an antioxidant cocktail for insulin resistance associated with age and a high sugar diet: a hepatic mechanism, in Nutrition, Diet Therapy, and the Liver (Preedy VR, Srirajaskanthan R, Lakshman R, and Watson RR eds) Chapter 21, 319-333, Taylor and Francis, CRC Press, London.
10. Lautt WW, Macedo MP, Sadri P, Takayama S, Ramos FD, and Legare DJ (2001) Hepatic parasympathetic (HISS) control of insulin sensitivity determined by feeding and fasting. Am J Physiol Gastrointest Liver Physiol 281:G29-G36. (Pubitemid 32916492)
11. Lautt WW, Ming Z, Macedo MP, and Legare DJ (2008) HISS-dependent insulin resistance (HDIR) in aged rats is associated with adiposity, progresses to syndrome X, and is attenuated by a unique antioxidant cocktail. Exp Gerontol 43:790-800.
12. Lautt WW, Ming Z, and Legare DJ (2010) Attenuation of age- and sucrose-induced insulin resistance and syndrome X by a synergistic antioxidant cocktail: Canadian Oxidative Stress Consortium Paper. Can J Physiol Pharmacol, in press.
13. Lautt WW, Wang X, Sadri P, Legare DJ, and Macedo MP (1998) Rapid insulin sensitivity test. Can J Physiol Pharmacol 76:1080-1086.
14. Moore MC, Satake S, Baranowski B, Hsieh P-S, Neal DW, and Cherrington AD (2002) Effect of hepatic denervation on peripheral insulin sensitivity in conscious dogs. Am J Physiol 282:E286-E296. (Pubitemid 34654798)
15. Ming Z, Legare DJ, and Lautt WW (2009) Obesity, syndrome X, and diabetes: the role of HISS-dependent insulin resistance altered by sucrose, an antioxidant cocktail, and age. Can J Physiol Pharmacol 87:873-882.
16. Patarrão RS, Lautt WW, Afonso RA, Ribeiro RT, Guarino MP, Fernandes AB, Boavida JM, and Macedo MP (2008) Meal-induced insulin sensitization and its parasympathetic regulation in humans. Can J Physiol Pharmacol 86:880-888.
17. Ribeiro RT, Afonso RA, Guarino MP, and Macedo MP (2008) Loss of postprandial insulin sensitization during aging. J Gerontol A Biol Sci Med Sci 63:560-565.
18. Sadri P and Lautt WW (1999) Blockade of hepatic nitric oxide synthase causes insulin resistance. Am J Physiol 277:G101-G108. (Pubitemid 29352650)
19. Sadri P and Lautt WW (2000) Insulin resistance caused by hepatic COX inhibition. Diabetes 49:A245.
20. Sadri P, Reid MAG, Afonso RA, Schafer J, Legare DJ, Macedo MP, and Lautt WW (2006) Meal-induced insulin sensitization in conscious and anaesthetized rat models comparing liquid mixed meal with glucose and sucrose. Br J Nutr 94:1-8.
21. Takayama S, Legare DJ, and Lautt WW (2000) Dose-related atropine-induced insulin resistance: comparing intraportal versus intravenous administration. Proc West Pharmacol Soc 43:33-34.
22. Tateishi N, Higashi T, Naruse A, Nakashima K, and Shiozaki H (1997) Rat liver glutathione: possible role as a reservoir of cysteine. J Nutr 107:51-60.
23. Terry AV Jr. and Buccafusco JJ (2003) The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J Pharmacol Exp Ther 306:821-827.
24. Xie H and Lautt WW (1995) Induction of insulin resistance by cholinergic blockade with atropine in the cat. J Autonom Pharmacol 15:361-369.
25. Xie H and Lautt WW (1996) Insulin resistance caused by hepatic cholinergic interruption and reversed by acetylcholine administration. Am J Physiol 271:E587-E592. (Pubitemid 126757553)
26. Xie H, Tsybenko VA, Johnson MV, and Lautt WW (1993) Insulin resistance of glucose response produced by hepatic denervation. Can J Physiol Pharmacol 71:175-178. (Pubitemid 23205430)